The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership (Q37609487)

21 August 2017

1 reference

title

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership (English)

1 reference

21 August 2017

1 reference

1 reference

Marie Perrault

1

1 reference

PubMed ID

19807698

21 August 2017

Eve-Isabelle Pécheur

series ordinal

2

1 reference

PubMed ID

19807698

21 August 2017

language of work or name

English

0 references

publication date

12 October 2009

1 reference

21 August 2017

1 reference

21 August 2017

423

1 reference

21 August 2017

3

1 reference

21 August 2017

303-314

1 reference

Global challenges in liver disease

21 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The role of ribavirin in the combination therapy of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Association of hepatitis C virus in human sera with beta-lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus particles and lipoprotein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Interaction of hepatitis C virus proteins with host cell membranes and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Identification of hepatitis C virus by immunoelectron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus particle detected by immunoelectron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Characterization of functional hepatitis C virus envelope glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Biogenesis of hepatitis C virus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus entry into host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cell entry of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

21 January 2018

Hepatitis C virus entry

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The Plasma Lipoproteins: Structure and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Liver extracellular matrix in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Computer morphometry for quantitative measurement of liver fibrosis: comparison with Knodell's score, colorimetry and conventional description reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Heparan sulfate: anchor for viral intruders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Heparan sulphate proteoglycans and viral vectors : ally or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Identification of glycosaminoglycan-binding sites within hepatitis C virus envelope glycoprotein E2*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The maintenance and generation of membrane polarity in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Morphogenesis of the polarized epithelial cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The cellular biology of scavenger receptor class B type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus receptor expression in normal and diseased liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Apolipoprotein C1 Association with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The tetraspanin web modulates immune-signalling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

A physical and functional link between cholesterol and tetraspanins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Lateral organization of membrane proteins: tetraspanins spin their web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Structure-function analysis of hepatitis C virus envelope-CD81 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Structural integrity of hepatocyte tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Freeze-fracture electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Claudins in occluding junctions of humans and flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The roles of claudin superfamily proteins in paracellular transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Virology: Final entry key for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

A key claudin extracellular loop domain is critical for epithelial barrier integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Virus entry by macropinocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Mechanisms of membrane fusion: disparate players and common principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

21 January 2018

Viral membrane fusion

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

The pH sensor for flavivirus membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Class III viral membrane fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Lipids as modulators of membrane fusion mediated by viral fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Fluorescence method for measuring the kinetics of fusion between biological membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091000

21 January 2018

Identifiers

DOI

10.1042/BJ20091000

1 reference

21 August 2017

1 reference

PubMed ID

19807698